Elias Kouchakji
2019
In 2019, Elias Kouchakji earned a total compensation of $5M as Senior Vice President, Clinical Development, Drug Safety, and Pharmacovigilance at FibroGen.
Compensation breakdown
| Non-Equity Incentive Plan | $292,600 |
|---|---|
| Option Awards | $1,697,417 |
| Salary | $550,000 |
| Stock Awards | $2,424,486 |
| Other | $20,586 |
| Total | $4,985,088 |
Kouchakji received $2.4M in stock awards, accounting for 49% of the total pay in 2019.
Kouchakji also received $292.6K in non-equity incentive plan, $1.7M in option awards, $550K in salary and $20.6K in other compensation.
Rankings
In 2019, Elias Kouchakji's compensation ranked 2,200th out of 13,971 executives tracked by ExecPay. In other words, Kouchakji earned more than 84.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,200 out of 13,971 | 84th |
Division Manufacturing | 798 out of 5,695 | 86th |
Major group Chemicals And Allied Products | 252 out of 2,194 | 89th |
Industry group Drugs | 204 out of 1,880 | 89th |
Industry Pharmaceutical Preparations | 149 out of 1,392 | 89th |
Source: SEC filing on April 23, 2020.
Kouchakji's colleagues
We found five more compensation records of executives who worked with Elias Kouchakji at FibroGen in 2019.